查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386279

經導管主動脈瓣置換術 (TAVR) 市場報告：2030 年趨勢、預測與競爭分析

Transcatheter Aortic Valve Replacement (TAVR) Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

經導管主動脈瓣置換術 (TAVR) 趨勢與預測

預計到 2030 年，全球經導管主動脈瓣置換術 (TAVR) 市場將達到 198 億美元，2024 年至 2030 年複合年成長率為 16.5%。該市場的主要促進因素是主動脈瓣狹窄病例數量的增加、瓣膜置換術微創手術的需求不斷成長以及 TAVR 設備的持續技術進步。全球經導管主動脈瓣置換術（TAVR）市場未來性廣闊，醫院市場和門診手術中心市場機會龐大。

經導管主動脈瓣置換術 (TAVR) 市場洞察

Lucintel 預測無縫線瓣膜在預測期內將出現高速成長。

預計北美地區在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而促使市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球經導管主動脈瓣置換術（TAVR）市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球經導管主動脈瓣置換術（TAVR）市場趨勢（2018-2023）與預測（2024-2030）
  • 依產品類型分類的全球經導管主動脈瓣置換術 (TAVR) 市場
    • 經導管主動脈瓣
    • 無縫線瓣膜
    • 其他
  • 依材料分類的全球經導管主動脈瓣置換術 (TAVR) 市場
    • 不銹鋼
    • 鎳鈦合金
    • 鈷鉻合金
    • 其他
  • 以最終用途分類的全球經導管主動脈瓣置換術 (TAVR) 市場
    • 醫院
    • 門診手術中心
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球經導管主動脈瓣置換術（TAVR）市場（依地區）
  • 北美經導管主動脈瓣置換術 (TAVR) 市場
  • 歐洲經導管主動脈瓣置換術（TAVR）市場
  • 亞太地區經導管主動脈瓣置換術 (TAVR) 市場
  • 其他地區經導管主動脈瓣置換術（TAVR）市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依產品類型分類的全球經導管主動脈瓣置換術 (TAVR) 市場成長機會
    • 全球經導管主動脈瓣置換術 (TAVR) 市場材料成長機會
    • 全球經導管主動脈瓣置換術 (TAVR) 市場成長機會（以最終用途）
    • 全球經導管主動脈瓣置換術 (TAVR) 市場成長機會（依地區）
  • 全球經導管主動脈瓣置換術 (TAVR) 市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球經導管主動脈瓣置換術 (TAVR) 市場容量擴張
    • 全球經導管主動脈瓣置換術 (TAVR) 市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • CryoLife
  • Abbott
  • Micro Interventional Devices
  • Boston Scientific
  • LivaNova
  • Meril Life Sciences
  • Edwards Lifesciences
簡介目錄

Transcatheter Aortic Valve Replacement (TAVR) Trends and Forecast

The future of the global transcatheter aortic valve replacement (TAVR) market looks promising with opportunities in the hospital and ambulatory surgical centre markets. The global transcatheter aortic valve replacement (TAVR) market is expected to reach an estimated $19.8 billion by 2030 with a CAGR of 16.5% from 2024 to 2030. The major drivers for this market are rising cases of aortic stenosis, growing demand for minimally invasive procedures for valve replacement, and continuos technological advancements in TAVR devices.

A more than 150-page report is developed to help in your business decisions.

Transcatheter Aortic Valve Replacement (TAVR) by Segment

The study includes a forecast for the global transcatheter aortic valve replacement (TAVR) by product type, material, end use, and region.

Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Transcatheter Aortic Valve
  • Sutureless Valve
  • Others

Transcatheter Aortic Valve Replacement (TAVR) Market by Material [Shipment Analysis by Value from 2018 to 2030]:

  • Stainless Steel
  • Nitinol
  • Cobalt Chromium
  • Others

Transcatheter Aortic Valve Replacement (TAVR) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Ambulatory Surgical Centres
  • Others

Transcatheter Aortic Valve Replacement (TAVR) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Transcatheter Aortic Valve Replacement (TAVR) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies transcatheter aortic valve replacement (TAVR) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transcatheter aortic valve replacement (TAVR) companies profiled in this report include-

  • CryoLife
  • Abbott
  • Micro Interventional Devices
  • Boston Scientific
  • LivaNova
  • Meril Life Sciences
  • Edwards Lifesciences

Transcatheter Aortic Valve Replacement (TAVR) Market Insights

Lucintel forecasts that sutureless valve is expected to witness higher growth over the forecast period.

North America is expected to witness highest growth over the forecast period.

Features of the Global Transcatheter Aortic Valve Replacement (TAVR) Market

Market Size Estimates: Transcatheter aortic valve replacement (TAVR) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Transcatheter aortic valve replacement (TAVR) market size by product type, material, end use, and region in terms of value ($B).

Regional Analysis: Transcatheter aortic valve replacement (TAVR) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, materials, end uses, and regions for the transcatheter aortic valve replacement (TAVR) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transcatheter aortic valve replacement (TAVR) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the transcatheter aortic valve replacement (TAVR) market size?

Answer: The global transcatheter aortic valve replacement (TAVR) market is expected to reach an estimated $19.8 billion by 2030.

Q.2 What is the growth forecast for transcatheter aortic valve replacement (TAVR) market?

Answer: The global transcatheter aortic valve replacement (TAVR) market is expected to grow with a CAGR of 16.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the transcatheter aortic valve replacement (TAVR) market?

Answer: The major drivers for this market are rising cases of aortic stenosis, growing demand for minimally invasive procedures for valve replacement, and continuos technological advancements in TAVR devices.

Q4. What are the major segments for transcatheter aortic valve replacement (TAVR) market?

Answer: The future of the transcatheter aortic valve replacement (TAVR) market looks promising with opportunities in the hospital and ambulatory surgical centre markets.

Q5. Who are the key transcatheter aortic valve replacement (TAVR) market companies?

Answer: Some of the key transcatheter aortic valve replacement (TAVR) companies are as follows:

  • CryoLife
  • Abbott
  • Micro Interventional Devices
  • Boston Scientific
  • LivaNova
  • Meril Life Sciences
  • Edwards Lifesciences

Q6. Which transcatheter aortic valve replacement (TAVR) market segment will be the largest in future?

Answer: Lucintel forecasts that sutureless valve is expected to witness higher growth over the forecast period.

Q7. In transcatheter aortic valve replacement (TAVR) market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the transcatheter aortic valve replacement (TAVR) market by product type (transcatheter aortic valve, sutureless valve, and others), material (stainless steel, nitinol, cobalt chromium, and others), end use (hospitals, ambulatory surgical centres, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Transcatheter Aortic Valve Replacement (TAVR) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Transcatheter Aortic Valve Replacement (TAVR) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type
    • 3.3.1: Transcatheter Aortic Valve
    • 3.3.2: Sutureless Valve
    • 3.3.3: Others
  • 3.4: Global Transcatheter Aortic Valve Replacement (TAVR) Market by Material
    • 3.4.1: Stainless Steel
    • 3.4.2: Nitinol
    • 3.4.3: Cobalt Chromium
    • 3.4.4: Others
  • 3.5: Global Transcatheter Aortic Valve Replacement (TAVR) Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Ambulatory Surgical Centres
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Transcatheter Aortic Valve Replacement (TAVR) Market by Region
  • 4.2: North American Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.2.2: North American Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others
  • 4.3: European Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.3.1: European Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type: Transcatheter Aortic Valve, Sutureless Valve, and Others
    • 4.3.2: European Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others
  • 4.4: APAC Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.4.1: APAC Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type: Transcatheter Aortic Valve, Sutureless Valve, and Others
    • 4.4.2: APAC Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others
  • 4.5: ROW Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.5.1: ROW Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type: Transcatheter Aortic Valve, Sutureless Valve, and Others
    • 4.5.2: ROW Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by Material
    • 6.1.3: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by End Use
    • 6.1.4: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by Region
  • 6.2: Emerging Trends in the Global Transcatheter Aortic Valve Replacement (TAVR) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Transcatheter Aortic Valve Replacement (TAVR) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transcatheter Aortic Valve Replacement (TAVR) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: CryoLife
  • 7.2: Abbott
  • 7.3: Micro Interventional Devices
  • 7.4: Boston Scientific
  • 7.5: LivaNova
  • 7.6: Meril Life Sciences
  • 7.7: Edwards Lifesciences